SPECT/CT in sentinel node imaging

Nuclear Medicine Communications

Volumn 34, Issue 3, 2013, Pages 191-202

  Wagner, Thomas ^a   Buscombe, John ^c   Gnanasegaran, Gopinath ^b   Navalkissoor, Shaunak ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^c ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

Breast cancer; Lymphoscintigraphy; Melanoma; Oropharyngeal squamous cell cancers; Sentinel node; Single photon emission computed tomography computed tomography

Indexed keywords

BREAST CANCER; COMPUTED TOMOGRAPHY SCANNER; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; ENDOMETRIUM CANCER; FALSE POSITIVE RESULT; HEALTH CARE QUALITY; HUMAN; INJECTION SITE; KIDNEY CARCINOMA; LYMPHATIC DRAINAGE; LYMPHOSCINTIGRAPHY; MELANOMA; MOUTH SQUAMOUS CELL CARCINOMA; PENIS CANCER; PREDICTIVE VALUE; PROSTATE CANCER; RADIATION DOSE; REVIEW; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SOLID TUMOR; SQUAMOUS CELL CARCINOMA; SURGICAL APPROACH; SYSTEMATIC REVIEW; TESTIS CANCER; VULVA CANCER;

FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; LYMPHOSCINTIGRAPHY; MALE; NEOPLASMS; REPRODUCIBILITY OF RESULTS; SENTINEL LYMPH NODE BIOPSY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84873409903     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/MNM.0b013e32835c5a24     Document Type: Review

References (57)

1. Wagner JD, Schauwecker D, Davidson D, Coleman JJ III, Saxman S, Hutchins G, et al. Prospective study of fluorodeoxyglucose-positron emission tomography imaging of lymph node basins in melanoma patients undergoing sentinel node biopsy. J Clin Oncol 1999; 17:1508-1515.
2. Acland KM, Healy C, Calonje E, O'Doherty M, Nunan T, Page C, et al. Comparison of positron emission tomography scanning and sentinel node biopsy in the detection of micrometastases of primary cutaneous malignant melanoma. J Clin Oncol 2001; 19:2674-2678.
3. Belhocine T, Pierard G, De Labrassinne M, Lahaye T, Rigo P. Staging of regional nodes in AJCC stage I and II melanoma: 18FDG PET imaging versus sentinel node detection. Oncologist 2002; 7:271-278.
4. Wagner JD, Schauwecker D, Davidson D, Logan T, Coleman JJ 3rd, Hutchins G, et al. Inefficacy of F-18 fluorodeoxy-D-glucose-positron emission tomography scans for initial evaluation in early-stage cutaneous melanoma. Cancer 2005; 104:570-579.
5. Veit-Haibach P, Vogt FM, Jablonka R, Kuehl H, Bockisch A, Beyer T, et al. Diagnostic accuracy of contrast-enhanced FDG-PET/CT in primary staging of cutaneous malignant melanoma. Eur J Nucl Med Mol Imaging 2009; 36:910-918.
6. Cheng G, Kurita S, Torigian DA, Alavi A. Current status of sentinel lymphnode biopsy in patients with breast cancer. Eur J Nucl Med Mol Imaging 2011; 38:562-575.
7. Buscombe J, Paganelli G, Burak ZE, Waddington W, Maublant J, Prats E, et al. Sentinel node in breast cancer procedural guidelines. Eur J Nucl Med Mol Imaging 2007; 34:2154-2159.
8. van der Ploeg IM, Valdes Olmos RA, Nieweg OE, Rutgers EJ, Kroon BB, Hoefnagel CA. The additional value of SPECT/CT in lymphatic mapping in breast cancer and melanoma. J Nucl Med 2007; 48:1756-1760.
9. Lerman H, Metser U, Lievshitz G, Sperber F, Shneebaum S, Even-Sapir E. Lymphoscintigraphic sentinel node identification in patients with breast cancer: The role of SPECT-CT. Eur J Nucl Med Mol Imaging 2006; 33: 329-337.
10. Husarik DB, Steinert HC. Single-photon emission computed tomography/ computed mography for sentinel node mapping in breast cancer. Semin Nucl Med 2007; 37:29-33.
11. Lerman H, Lievshitz G, Zak O, Metser U, Schneebaum S, Even-Sapir E. Improved sentinel node identification by SPECT/CT in overweight patients with breast cancer. J Nucl Med 2007; 48:201-206.
12. Ibusuki M, Yamamoto Y, Kawasoe T, Shiraishi S, Tomiguchi S, Yamashita Y, et al. Potential advantage of preoperative three-dimensional mapping of sentinel nodes in breast cancer by a hybrid single photon emission CT (SPECT)/CT system. Surg Oncol 2010; 19:88-94.
13. van der Ploeg IM, Olmos RA, Kroon BB, Rutgers EJ, Nieweg OE. The hidden sentinel node and SPECT/CT in breast cancer patients. Eur J Nucl Med Mol Imaging 2009; 36:6-11.
14. Coffey JP, Hill JC. Breast sentinel node imaging with low-dose SPECT/CT. Nucl Med Commun 2010; 31:107-111.
15. Mucientes Rasilla J, Farge Balbin L, Cardona Arbonies J, Moreno Elola- Olaso A, Delgado-Bolton R, Izarduy Pereyra L, et al. SPECT-CT: A new tool for localisation of sentinel lymph nodes in breast cancer patients. Rev Esp Med Nucl 2008; 27:183-190.
16. Van der Ploeg IM, Nieweg OE, Kroon BB, Rutgers EJ, Baas-Vrancken Peeters MJ, Vogel WV, et al. The yield of SPECT/CT for anatomical lymphatic mapping in patients with breast cancer. Eur J Nucl Med Mol Imaging 2009; 36:903-909.
17. Gallowitsch HJ, Kraschl P, Igerc I, Hussein T, Kresnik E, Mikosch P, et al. Sentinel node SPECT-CT in breast cancer. Can we expect any additional and clinically relevant information? Nuklearmedizin 2007; 46:252-256.
18. Morton DL, Thompson JF, Cochran AJ, Mozzillo N, Elashoff R, Essner R, et al. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med 2006; 355:1307-1317.
19. Chakera AH, Hesse B, Burak Z, Ballinger JR, Britten A, Caraco C, et al. EANM-EORTC general recommendations for sentinel node diagnostics in melanoma. Eur J Nucl Med Mol Imaging 2009; 36:1713-1742.
20. Uren RF. SPECT/CT Lymphoscintigraphy to locate the sentinel lymph node in patients with melanoma. Ann Surg Oncol 2009; 16:1459-1460.
21. Even-Sapir E, Lerman H, Lievshitz G, Khafif A, Fliss DM, Schwartz A, et al. Lymphoscintigraphy for sentinel node mapping using a hybrid SPECT/CT system. J Nucl Med 2003; 44:1413-1420.
22. Ishihara T, Kaguchi A, Matsushita S, Shiraishi S, Tomiguchi S, Yamashita Y, et al. Management of sentinel lymph nodes in malignant skin tumors using dynamic lymphoscintigraphy and the single-photon-emission computed tomography/computed tomography combined system. Int J Clin Oncol 2006; 11:214-220.
23. Van der Ploeg IM, Valdes Olmos RA, Kroon BB, Wouters MW, van den Brekel MW, Vogel WV, et al. The yield of SPECT/CT for anatomical lymphatic mapping in patients with melanoma. Ann Surg Oncol 2009; 16:1537-1542.
24. Covarelli P, Tomassini GM, Simonetti S, Messina S, Cini C, Petrina A, et al. The single-photon emission computed tomography/computed tomography: A new procedure to perform the sentinel node biopsy in patients with head and neck melanoma. Melanoma Res 2007; 17:323-328.
25. Kretschmer L, Altenvoerde G, Meller J, Zutt M, Funke M, Neumann C, et al. Dynamic lymphoscintigraphy and image fusion of SPECT and pelvic CTscans allow mapping of aberrant pelvic sentinel lymph nodes in malignant melanoma. Eur J Cancer 2003; 39:175-183.
26. Mucientes Rasilla J, Cardona Arbonies J, Delgado Bolton R, Izarduy Pereyra L, Salazar Andia G, Prieto Soriano A, et al. SPECT-CT in sentinel node detection in patients with melanoma. Rev Esp Med Nucl 2009; 28: 229-234.
27. Vermeeren L, Valdes Olmos RA, Klop WM, van der Ploeg IM, Nieweg OE, Balm AJ, et al. SPECT/CT for sentinel lymph node mapping in head and neck melanoma. Head Neck 2011; 33:1-6.
28. Nielsen KR, Chakera AH, Hesse B, Scolyer RA, Stretch JF, Thompson JF, et al. The diagnostic value of adding dynamic scintigraphy to standard delayed planar imaging for sentinel node identification in melanoma patients. Eur J Nucl Med Mol Imaging 2011; 38:1999-2004.
29. Veenstra HJ, Vermeeren L, Olmos RA, Nieweg OE. The additional value of lymphatic mapping with routine SPECT/CT in unselected patients with clinically localized melanoma. Ann Surg Oncol 2012; 19:1018-1023.
30. Klode J, Poeppel T, Boy C, Mueller S, Schadendorf D, Korber A, et al. Advantages of preoperative hybrid SPECT/CT in detection of sentinel lymph nodes in cutaneous head and neck malignancies. J Eur Acad Dermatol Venereol 2011; 25:1213-1221.
31. Klop WM, Veenstra HJ, Vermeeren L, Nieweg OE, Balm AJ, Lohuis PJ. Assessment of lymphatic drainage patterns and implications for the extent of neck dissection in head and neck melanoma patients. J Surg Oncol 2011; 103:756-760.
32. Uren RF, Howman-Giles R, Thompson JF. Patterns of lymphatic drainage from the skin in patients with melanoma. J Nucl Med 2003; 44:570-582.
33. Alex JC, Krag DN. The gamma-probe-guided resection of radiolabeled primary lymph nodes. Surg Oncol Clin N Am 1996; 5:33-41.
34. Alkureishi LW, Ross GL, Shoaib T, Soutar DS, Robertson AG, Thompson R, et al. Sentinel node biopsy in head and neck squamous cell cancer: 5-year follow-up of a European multicenter trial. Ann Surg Oncol 2010; 17: 2459-2464.
35. Murer K, Huber GF, Haile SR, Stoeckli SJ. Comparison of morbidity between sentinel node biopsy and elective neck dissection for treatment of the n0
36. neck in patients with oral squamous cell carcinoma. Head Neck 2011; 33:1260-1264.
37. Haerle SK, Hany TF, Strobel K, Sidler D, Stoeckli SJ. Is there an additional value of SPECT/CT over planar lymphoscintigraphy for sentinel node mapping in oral/oropharyngeal squamous cell carcinomä Ann Surg Oncol 2009; 16:3118-3124.
38. Bilde A, Von Buchwald C, Mortensen J, Marving J, Hamilton Therkildsen M, Kirkegaard J, et al. The role of SPECT-CT in the lymphoscintigraphic identification of sentinel nodes in patients with oral cancer. Acta Otolaryngol 2006; 126:1096-1103.
39. Khafif A, Schneebaum S, Fliss DM, Lerman H, Metser U, Ben-Yosef R, et al. Lymphoscintigraphy for sentinel node mapping using a hybrid single photon emission CT (SPECT)/CT system in oral cavity squamous cell carcinoma. Head Neck 2006; 28:874-879.
40. Wagner A, Schicho K, Glaser C, Zettinig G, Yerit K, Lang S, et al. SPECT-CT for topographic mapping of sentinel lymph nodes prior to gamma probe-guided biopsy in head and neck squamous cell carcinoma. J Craniomaxillofac Surg 2004; 32:343-349.
41. Keski-Santti H, Matzke S, Kauppinen T, Tornwall J, Atula T. Sentinel lymph node mapping using SPECT-CT fusion imaging in patients with oral cavity squamous cell carcinoma. Eur Arch Otorhinolaryngol 2006; 263: 1008-1012.
42. Winter A, Wawroschek F. Lymphadenectomy in prostate cancer. Radioguided lymph node mapping: An adequate staging method. Front Radiat Ther Oncol 2008; 41:58-67.
43. Vermeeren L, Valdes Olmos RA, Meinhardt W, Bex A, van der Poel HG, Vogel WV, et al. Value of SPECT/CT for detection and anatomic localization of sentinel lymph nodes before laparoscopic sentinel node lymphadenectomy in prostate carcinoma. J Nucl Med 2009; 50:865-870.
44. Krengli M, Ballare A, Cannillo B, Rudoni M, Kocjancic E, Loi G, et al. Potential advantage of studying the lymphatic drainage by sentinel node technique and SPECT-CT image fusion for pelvic irradiation of prostate cancer. Int J Radiat Oncol Biol Phys 2006; 66:1100-1104.
45. Seo Y, Aparici CM, Chen CP, Hsu C, Kased N, Schreck C, et al. Mapping of lymphatic drainage from the prostate using filtered 99mTc-sulfur nanocolloid and SPECT/CT. J Nucl Med 2011; 52:1068-1072.
46. Vermeeren L, Meinhardt W, Valdes Olmos RA. Prostatic lymphatic drainage with sentinel nodes at the ventral abdominal wall visualized with SPECT/CT: A case series. Clin Nucl Med 2010; 35:71-73.
47. Vermeeren L, Meinhardt W, van der Poel HG, Valdes Olmos RA. Lymphatic drainage from the treated versus untreated prostate: Feasibility of sentinel node biopsy in recurrent cancer. Eur J Nucl Med Mol Imaging 2010; 37:2021-2026.
48. Martinez A, Zerdoud S, Mery E, Bouissou E, Ferron G, Querleu D. Hybrid imaging by SPECT/CT for sentinel lymph node detection in patients with cancer of the uterine cervix. Gynecol Oncol 2010; 119:431-435.
49. Diaz-Feijoo B, Perez-Benavente MA, Cabrera-Diaz S, Gil-Moreno A, Roca I, Franco-Camps S, et al. Change in clinical management of sentinel lymph node location in early stage cervical cancer: The role of SPECT/CT. Gynecol Oncol 2011; 120:353-357.
50. Pandit-Taskar N, Gemignani ML, Lyall A, Larson SM, Barakat RR, Abu Rustum NR. Single photon emission computed tomography SPECT-CT improves sentinel node detection and localization in cervical and uterine malignancy. Gynecol Oncol 2010; 117:59-64.
51. Freudenberg LS, Gortz E, Hagen C, Harms E, KoskaWW, Marlowe RJ, et al. Lymphatic mapping using SPECT/CT in vulvar carcinoma. Clin Nucl Med 2010; 35:950-952.
52. Cabanas RM. An approach for the treatment of penile carcinoma. Cancer 1977; 39:456-466.
53. Leijte JA, Valdes Olmos RA, Nieweg OE, Horenblas S. Anatomical mapping of lymphatic drainage in penile carcinoma with SPECT-CT: Implications for the extent of inguinal lymph node dissection. Eur Urol 2008; 54:885-890.
54. Leijte JA, van der Ploeg IM, Valdes Olmos RA, Nieweg OE, Horenblas S. Visualization of tumor blockage and rerouting of lymphatic drainage in penile cancer patients by use of SPECT/CT. J Nucl Med 2009; 50:364-367.
55. Bex A, Vermeeren L, Meinhardt W, Prevoo W, Horenblas S, Valdes Olmos RA. Intraoperative sentinel node identification and sampling in clinically node-negative renal cell carcinoma: Initial experience in 20 patients. World J Urol 2011; 29:793-799.
56. Brouwer OR, Valdes Olmos RA, Vermeeren L, Hoefnagel CA, Nieweg OE, Horenblas S. SPECT/CT and a portable gamma-camera for image-guided laparoscopic sentinel node biopsy in testicular cancer. J Nucl Med 2011; 52:551-554.
57. Vermeeren L, MeinhardtW, Bex A, van der Poel HG,VogelWV, Hoefnagel CA, et al. Paraaortic sentinel lymph nodes: Toward optimal detection and intraoperative localization using SPECT/CT and intraoperative real-time imaging. J Nucl Med 2010; 51:376-382.